Global Health (Australia) Today

GLH Stock   0.13  0.01  7.14%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Over 88

 
High
 
Low
Very High
Global Health is selling for under 0.13 as of the 17th of January 2025; that is 7.14 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 0.13. Global Health has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 18th of November 2024 and ending today, the 17th of January 2025. Click here to learn more.
Business Domain
Health Care Equipment & Services
Category
Healthcare
Classification
Health Care
Global Health is entity of Australia. It is traded as Stock on AU exchange. The company has 58.05 M outstanding shares. More on Global Health

Moving against Global Stock

  0.66QAN Qantas AirwaysPairCorr
  0.61QBE Qbe Insurance GroupPairCorr
  0.6CBA Commonwealth BankPairCorr
  0.52VUL Vulcan Energy ResourcesPairCorr
  0.52DSE DropsuitePairCorr
  0.51PNI Pinnacle InvestmentPairCorr

Global Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Global Health's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Global Health or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Thematic IdeaHealth Management (View all Themes)
Business ConcentrationHealth Care Technology, Health Care Equipment & Services, Health Care, Health Management, Health Care, Health Care Technology, Health Care Equipment & Services, Health Care (View all Sectors)
Global Health's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Global Health's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Debt Levels
Global Health can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Global Health's financial leverage. It provides some insight into what part of Global Health's total assets is financed by creditors.
Liquidity
Global Health cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. Global Health has accumulated 1.03 M in total debt. Debt can assist Global Health until it has trouble settling it off, either with new capital or with free cash flow. So, Global Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Global Health sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Global to invest in growth at high rates of return. When we think about Global Health's use of debt, we should always consider it together with cash and equity.

Total Cash From Financing Activities

638,422
Global Health (GLH) is traded on Australian Securities Exchange in Australia and employs 10 people. Global Health is listed under Health Care Technology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 7.55 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Global Health's market, we take the total number of its shares issued and multiply it by Global Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Global Health operates under Health Care Technology sector and is part of Health Care industry. The entity has 58.05 M outstanding shares. Global Health generates negative cash flow from operations
Check Global Health Probability Of Bankruptcy
Ownership Allocation
Global Health has a total of 58.05 Million outstanding shares. Global Health retains majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 79.71 (percent) of Global Health outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Global Ownership Details

Global Health Risk Profiles

Although Global Health's alpha and beta are two of the key measurements used to evaluate Global Health's performance over the market, the standard measures of volatility play an important role as well.

Global Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Global Health without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Content Syndication Now

   

Content Syndication

Quickly integrate customizable finance content to your own investment portal
All  Next Launch Module

Global Health Corporate Management

Elected by the shareholders, the Global Health's board of directors comprises two types of representatives: Global Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Global. The board's role is to monitor Global Health's management team and ensure that shareholders' interests are well served. Global Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Global Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Robin ArmstrongRegional FocusProfile
Kye CherianChief OfficerProfile
Jessica MooreVice RelationsProfile
Deborah HudsonMa GroupProfile
James CPACompany SecretaryProfile
Stuart CroninChief OfficerProfile

Additional Tools for Global Stock Analysis

When running Global Health's price analysis, check to measure Global Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Global Health is operating at the current time. Most of Global Health's value examination focuses on studying past and present price action to predict the probability of Global Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Global Health's price. Additionally, you may evaluate how the addition of Global Health to your portfolios can decrease your overall portfolio volatility.